Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 13/20 | 0.84 |
| ▸ | MEN1 | O00255 | 12/20 | 0.84 |
| ▸ | RAB9A | P51151 | 11/20 | 0.84 |
| ▸ | NPC1 | O15118 | 9/20 | 0.84 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.84 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.84 |
| ▸ | RECQL | P46063 | 4/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.81 |
| ▸ | MAPT | P10636 | 6/20 | 0.81 |
| ▸ | POLB | P06746 | 5/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.81 |
| ▸ | PKM | P14618 | 3/20 | 0.81 |
| ▸ | BLM | P54132 | 2/20 | 0.81 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | SLC12A2 | P55011 | 1/20 | 0.59 |
| ▸ | SLC12A5 | Q9H2X9 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | UBE2I | P63279 | 1/20 | 0.55 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1893060 | 1.00 | KMT2A (0.84) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL1892079 | 0.90 | KMT2A (1.00) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL12271549 | 0.90 | KMT2A (0.84) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL1892078 | 0.90 | KMT2A (1.00) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL12319226 | 0.84 | KMT2A (0.84) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL12756716 | 0.81 | MEN1 (0.56) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL1954658 | 0.79 | MEN1 (0.82) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL7951624 | 0.79 | KMT2A (0.62) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL12319233 | 0.79 | KMT2A (0.62) | KMT2AMEN1RAB9ANPC1TDP1 | |
| SCHEMBL12319219 | 0.78 | RAB9A (0.66) | KMT2AMEN1RAB9ANPC1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130245025-A1 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8394848-B2 | Compounds that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-03-12 | — | — | US | disclosed |
| US-8383670-B2 | Trisubstituted thiophenes that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| CN-102256969-A | Compounds that modulate intracellular calcium | CALCIMEDICA INC | 2011-11-23 | — | — | CN | disclosed |
| US-20110212970-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2011-09-01 | — | — | US | disclosed |
| US-20110136816-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2011-06-09 | — | — | US | disclosed |
| EP-2321303-A2 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | Calcimedica, Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| US-7906553-B2 | Substituted thiophene modulators of intracellular calcium | CALCIMEDICA, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| US-20100261725-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2010-10-14 | — | — | US | disclosed |
| WO-2010027875-A2 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA INC. (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261725-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | KMT2A 4706/4885MEN1 2958/4885RAB9A 1174/4885 |
| US-20110212970-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | KMT2A 4706/4885MEN1 2958/4885RAB9A 1174/4885 |
| US-20130245025-A1 | Compounds that modulate intracellular calcium | ORAI1, SARAF, RYR2 | KMT2A 4706/4885MEN1 2958/4885RAB9A 1174/4885 |
| US-20110136816-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | KMT2A 4706/4885MEN1 2958/4885RAB9A 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.